Mylan Beats On Q2 Earnings, Revenues In Line
Mylan N.V.(MYL – Analyst Report) is one of the largest generics and specialty pharmaceutical companies in the globe. The company’s product portfolio encompasses various therapeutic areas including cardiovascular, central nervous system, anti-infective, gastrointestinal, endocrine and metabolic, and respiratory drugs. Mylan continued to launch generic drugs in the second quarter of 2015. The investor focus will remain on…